A protein called Runx2 contributes to the abnormal activity of lung cells that drive pulmonary fibrosis, a new study shows.

Columnist Ann Reynoso, who's now preparing for a bilateral lung transplant, is counting on her strength and perseverance to ...

As snow falls at his home, columnist Sam Kirton remembers how he's had to accept limitations, especially since his bilateral ...

Nerandomilast worked better than a placebo to preserve lung function in adults with progressive pulmonary fibrosis in a Phase ...

Low total cholesterol levels were tied to an increased risk of death for pulmonary fibrosis patients with disease of unknown ...

Exercise is important for people with chronic illness. But as someone living with idiopathic pulmonary fibrosis (IPF), a disease characterized by progressive scarring of the lungs and difficulty ...

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

Mediar Therapeutics is planning to launch a Phase 2 clinical trial to test its experimental therapy MTX-463 in people with idiopathic pulmonary fibrosis (IPF). The company has entered into a global ...

We’re not all the same. When I share details about my journey with idiopathic pulmonary fibrosis (IPF), I don’t want to give the impression that I’m setting a standard. My goal in writing this column ...